HSBC Holdings
PLRX icon

HSBC Holdings’s Pliant Therapeutics PLRX Stock Holding History

HSBC Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,507
Closed -$156K – 3121
2024
Q1 		$156K Buy
+10,507
New +$173K ﹤0.01% 2747
2022
Q3 		– Sell
-18,070
Closed -$144K – 3195
2022
Q2 		$144K Buy
+18,070
New +$116K ﹤0.01% 2964
2021
Q1 		– Sell
-9,053
Closed -$209K – 3033
2020
Q4 		$209K Buy
+9,053
New +$227K ﹤0.01% 2793

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

HSBC Holdings's PLRX Position: Q2 2024 in Review

HSBC Holdings sold out of Pliant Therapeutics (PLRX) in Q2 2024, closing a stake of 10,507 shares — an estimated $156K sold.

HSBC Holdings first reported a position in PLRX in Q4 2020 and held it in 3 quarters. The position peaked at $209K in Q4 2020. 143 funds tracked by Wall St. Rank hold PLRX as of Q2 2024.

  • HSBC Holdings reported no remaining Pliant Therapeutics position as of Q2 2024 after selling out during the quarter.
  • HSBC Holdings sold 10,507 Pliant Therapeutics shares in Q2 2024, an estimated $156K.
  • HSBC Holdings first reported a position in Pliant Therapeutics in Q4 2020 and held it in 3 quarters.
  • HSBC Holdings's Pliant Therapeutics position peaked at $209K in Q4 2020.
  • 143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2024.

Based on HSBC Holdings's 13F filing for Q2 2024, filed 12 Aug 2024.